Now available EXDENSUR

EXDENSUR (depemokimab-ulaa) is an interleukin-5 (IL-5) antagonist, a monoclonal antibody (humanized immunoglobulin G [IgG]1 kappa) indicated for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.

 

Limitations of Use: Not for relief of acute bronchospasm or status asthmaticus.

View full prescribing information.